Block 주식 가격. SQ3 - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
독일
TG
Block Inc (SQ3) 시세

Block Inc (SQ3)

89.24

4.07

( 4.78% )

업데이트: 04:44:15

실시간 데이터

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

가격

89.24

매수가

89.06

매도가

89.24

거래량

36,337

85.21 일간 변동폭 89.65

48.755 52주 범위 89.65

market_cap

전일 종가

85.17

개장가

86.90

최근 거래 시간

마지막 거래 시간

04:44:03

재정 규모

-

VWAP

-

평균 볼륨(3m)

10,191

발행 주식

619,814,000

배당수익률

-

주가수익률

5,895.57

주당순이익(EPS)

0.02

매출

21.92B

순이익

9.77M

섹터

Prepackaged Software

산업

Prepackaged Software

웹사이트

www.block.xyz

본부

Wilmington, Delaware, USA

설립됨

-

Block Inc is listed in the Prepackaged Software sector of the Tradegate (DE) with ticker SQ3. The last closing price for Block was 85.17 €. Over the last year, Block shares have traded in a share price range of 48.755 € to 89.65 €.

Block currently has 619,814,000 shares in issue. The market capitalisation of Block is 52.79 € billion. Block has a price to earnings ratio (PE ratio) of 5895.57.

No news to show yet.

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	8.43	10.4318772429	80.81	89.65	77.65	19851	84.23810303	DE
4	22.6	33.9135654262	66.64	89.65	64.239999	17257	76.42618217	DE
12	32.21	56.4790461161	57.03	89.65	53.85	10191	70.29830286	DE
26	21.36	31.4672952269	67.88	89.65	48.755	8065	65.48657369	DE
52	34.88	64.1648270787	54.36	89.65	48.755	9429	66.11962095	DE
156	-110.38	-55.2950606152	199.62	199.98	36.57	6726	72.78395219	DE
260	-72.96	-44.9815043157	162.2	243.75	36.57	6129	95.2125868	DE

가장 활성
% 상승자
% 패자

기호	가격	볼륨
0S6Cerence Inc	5.987 € (123.31%)	72.26k
7S2Scotch Creek Ventures Inc	0.0144 € (67.44%)	5.61k
AOYAlpha and Omega Semiconductor Ltd	38.98 € (35.25%)	2.15k
5Q5Snowflake Inc	162.78 € (32.77%)	85.87k
ID4Recylico Battery Materials Inc	0.095 € (32.68%)	8.18k
BVU3St James Gold Corp	0.048 € (-54.72%)	250
AAJ0Perspective Therapeutics Inc	2.84 € (-51.45%)	970
9S70Critical Resources Limited	0.002 € (-50.00%)	5k
L7C2Windfall Geotek Inc	0.003 € (-45.45%)	16k
20MPMountain Valley MD Holdings Inc	0.0116 € (-38.95%)	39.5k
D7GNel ASA	0.2503 € (-7.94%)	16.37M
P1MPeninsula Energy Limited	0.0365 € (-1.08%)	6.33M
GHUADX Energy Ltd	0.0334 € (-17.33%)	2.13M
NVDNVIDIA Corp	141.02 € (1.85%)	1.48M
BT81PowerHouse Energy Group Plc	0.0122 € (0.00%)	1.11M

manibiotech

manibiotech 2 분 전

However the data of current trial submitted for approval is not "in vitro"

payupdeadbeat

payupdeadbeat 2 분 전

It is clear that the "investment of a lifetime* message is not getting out. I hope the longs are not being hornscwaggled.

Craig305

Craig305 3 분 전

This is the highest day volume since June 2022.

Serpico2005

Serpico2005 3 분 전

HUGE revenue pouring in here, we won't be denied, won't be able the hold it down much longer.

delerious1

delerious1 3 분 전

Milling results soon yet some say that this stock is garbage etc have been here as long as me or longer so that would mean plenty of time to see the patterns and make some really good money....but I bet that they haven't....so it is a bit of a conundrum....why wouldn't they when obviously given the

ExtremelyBullishZig

ExtremelyBullishZig 3 분 전

No...all biotechs are up based on gene editing company success it move the index

richme

richme 3 분 전

Need to Curb Your Enthusiasm just because the share price jumped all the way to $0.0166 share price,
-$0.0015 day change. Isn't that great? We will be heading to Mars soon....no less in Elon Musk's rocket ship or to hell in ________ (add your own).

Quintessence

Quintessence 3 분 전

PDYNW - Nice move today! I will consider buying dips.

JRoon71

JRoon71 3 분 전

TC, I get that. I just meant that in looking at what Italy pays for other drugs, what Amarin wants for Vazkepa is substantially more than MOST drugs on the list.

I'm not talking about the cost to patients, but the cost to the government.

If Vazkepa cost $15 to sell to

dennisdave

dennisdave 4 분 전

BTW, the three companies with approved PD1 inhibitors, which is what the U.S. patent office tried to narrow the combo patent to, are:

Merck = Keytruda

Opdivo = Bristol

Libtayo = Regeneron.
Thanks very helpful.

attilathehunt

attilathehunt 4 분 전

1 buy of 20k will work the same as 2 buys of 10k on squeeze day, no?

NO!!!!!

On squeeze day your first buy order will be much much lower than all subsequent ones...

For example, on Squeeze day (approval) if your first early open trade gets executed at 1.0

bgATL

bgATL 4 분 전

Gaetz is out, my opinion has been he was never really going to be in the position, as it was cover to let him resign from the House before the severe reprimands which could have ruined his chances of a future career. Trump also could now argue he tried to put a pot friendly guy in the office and it

I wonder if .0011 is a good entry? Fishing time. 🎣

konshe

konshe 4 분 전

Strong buy at ask 0.0002, paint sell at bid 0.0001. 0.0002 2mm shares will be gone soon.

al44

The world will become safer when the ‘adults in the room’ are… gone

By Jack Hellner

When Biden and his team of incompetents took over, the media cheered that finally the adults were back in the room; well thankfully, the “children” will be back soon and the U.S.

Real McCoy

Real McCoy 5 분 전

I think they think that announced participation in a hot industry segment should entitle them to valuation levels of those hot industry segment leaders. Despite ALWAYS having virtually no revenue.

KRISGO

KRISGO 5 분 전

Hello Dcaf7, based on the full abstract being released on Nov 25th, can the experts evaluate whether same-day dosing is effective and works better?

PennyMillions852

PennyMillions852 5 분 전

BID building here but...you KNOW what will come next......this is the type of chit that needs to stop for us to move up above .0003!

Hitman970

Hitman970 5 분 전

Why hasn't this historic moment made any mainstream press?
x / twitter and company generate PRs mean nothing.
You are repeating yourself over and over. Do you know Vic? You called him "benign" a while back.

CrashOverride

CrashOverride 5 분 전

If it was DCVax the 2016 paper would cite Liau or Prins as they are the leaders in the field of Dendritic-cell-based vaccines.

They had several papers published before 2016.

It doesn't so it isn't DCVax.

biotechinvestor1

biotechinvestor1 5 분 전

From another poster: “Evotec has already said no thanks. Wall Street said no thanks. When Halozyme management says ok forget about it, we go up $10. We are waiting Ms Helen.”

BamaBreeze

BamaBreeze 5 분 전

Can you bring in the update your referencing(please).

redspinelpinktopaz

redspinelpinktopaz 5 분 전

No. It seems all right to me.

glenn1919

glenn1919 5 분 전

TRNR....CISO....MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134

WinstonCup

WinstonCup 5 분 전

Sometimes you make no sense.

US Dollar vs MUR

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관